Robert E. Waltermire Madrigal Pharmaceuticals, Inc. (MDGL) insider trading activity

MDGL Quotes by TradingView

Robert E. Waltermire is Senior VP, Chief Pharma Dev. of MADRIGAL PHARMACEUTICALS, INC.. Currently has a direct ownership of 3,728 shares of MDGL, which is worth approximately $1.2 Million. The most recent transaction as insider was on Jan 16, 2023, when has been sold 5,667 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.73K
32.22% 3M change
42.96% 12M change
Total Value Held $1.2 Million

Robert E. Waltermire Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 16 2023
BUY
Grant, award, or other acquisition
-
5,667 Added 50.0%
5,667 Common Stock
REW

Robert E. Waltermire

Senior VP, Chief Pharma Dev.
West Conshohocken, PA

Track Institutional and Insider Activities on MDGL

Follow MADRIGAL PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MDGL shares.

Notify only if

Insider Trading

Get notified when an Madrigal Pharmaceuticals, Inc. insider buys or sells MDGL shares.

Notify only if

News

Receive news related to MADRIGAL PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MDGL